Colistin Sulfate molecular structure

Colistin Sulfate

Also known as: Coly-Mycin M (colistimethate), Colomycin, Polymyxin E

CAS Number: 1264-72-8

Polymyxin antibiotic — last-resort for carbapenem-resistant gram-negative bacteria

Pharmacopeia Standards

USPBPEP

Mechanism of Action

Cyclic polypeptide (lipopeptide) that disrupts gram-negative bacterial outer membrane integrity. Positively charged diaminobutyric acid residues displace Ca²⁺/Mg²⁺ stabilizing LPS, causing membrane permeability disruption, loss of osmotic control, and cell death. Bactericidal, concentration-dependent. Activity limited to gram-negative aerobes with lipopolysaccharide-containing outer membrane. Used as the inactive prodrug colistimethate sodium (CMS) for IV/inhalation.

Technical Specifications

Generic / INN NameColistin Sulfate
CAS Registry Number1264-72-8
Molecular FormulaCyclic polypeptide mixture (Polymyxin E1 / E2)
Molecular Weight~1750 g/mol
Typical PurityNLT 19,500 IU/mg (colistin sulfate) on dried basis
Storage ConditionsStore below 25°C, protect from light and moisture
Shelf Life24 months from date of manufacture
CategoryPolymyxins

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Last-resort treatment for carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa (CRPA), carbapenem-resistant Enterobacteriaceae (CRE) — often in combination. Inhaled colistimethate for cystic fibrosis chronic Pseudomonas colonization. Oral colistin sulfate for gut decontamination. Animal growth promotion (now banned in many countries).

Manufacturers (1+)

View all →

India

WHO-GMPUS-FDAEU-GMP
Contact (Premium)